Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha CognitionACOG +2.43%35 Days Sales Outstanding is 79.17 as of Jun. 2026, which is 48% below its 10-year median of 151.29. GuruFocus rates ACOG with a GF Score™ of 35/100. The stock has 5 warning signs investors should review. Among 840 Biotechnology companies, Alpha Cognition ranks worse than 63.21% on this metric.
Alpha Cognition (NAS:ACOG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Alpha Cognition Days Sales Outstanding Related Terms
Alpha Cognition Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Alpha Cognition's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACOG vs MENS, NGEN, LENZ: Days Sales Outstanding Comparison
For the Biotechnology subindustry, Alpha Cognition's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Cognition Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Cognition's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Alpha Cognition's Days Sales Outstanding falls into.
Alpha Cognition Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Cognition (ACOG) has a Days Sales Outstanding of 79.17 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Alpha Cognition and its competitors. This is 48% below median its historical median of 151.29. Over the past decade, Alpha Cognition's Days Sales Outstanding has ranged from 89.17 to 151.29. According to the industry distribution chart, Alpha Cognition ranks #531 out of 840 companies in the Biotechnology industry, placing it in the top 63.2%.
Is Alpha Cognition's Days Sales Outstanding too high?
Alpha Cognition's current Days Sales Outstanding of 79.17 is 48% below median its 10-year median of 151.29. Over the past 10 years, this metric has ranged from a low of 89.17 to a high of 151.29. The Biotechnology industry median Days Sales Outstanding is 69.28. Alpha Cognition's value of 79.17 is 14.3% above this industry median. Based on the distribution chart, Alpha Cognition ranks #531 out of 840 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Days Sales Outstanding compare to MENS and NGEN?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #531 out of 840 companies for Days Sales Outstanding. This places Alpha Cognition in the lower half of its industry. The industry median Days Sales Outstanding is 69.28. Alpha Cognition's value of 79.17 is 14.3% above this benchmark. Historically, Alpha Cognition's own Days Sales Outstanding has ranged from 89.17 to 151.29 over the past decade. While the company's 10-year median is 151.29 vs. the industry median of 69.28, Alpha Cognition has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.28, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current Days Sales Outstanding of 79.17 is 14.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Alpha Cognition and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current Days Sales Outstanding is 79.17, which is 48% below median its own 10-year median of 151.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Days Sales Outstanding of 79.17. The current Days Sales Outstanding is 79.17, which is 48% below median its 10-year median of 151.29 and 14.3% above the Biotechnology industry median of 69.28. Alpha Cognition's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Days Sales Outstanding is 79.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
35GF Score
Get the complete analysis for ACOG
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACOG has been successfully added to your 
